ArticleScientific reports2024

Safety assessments and clinical features of PARP inhibitors from real-world data of Japanese patients with ovarian cancer.

Ryosuke Uekusa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.